Targeting CD47 in MDS and AML: An Emerging New Immunotherapy Approach

Gain expert insights on emerging treatment options targeting CD47 for myelodysplastic syndromes and acute myeloid leukemia with a downloadable slideset from a satellite symposium, an on-demand webcast, and an expert commentary.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

This program has been supported by an independent educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.